Navigation Links
WBAL Radio Segment With Dr. Leigh Vinocur Addresses Hope for the Rosacea Sufferer
Date:3/13/2009

- Dr. Vinocur Reports on University of California Rosacea-Specific Study -

NAPA, Calif., March 13 /PRNewswire-FirstCall/ -- On March 9, 2009, Dr. Leigh Vinocur, medical expert from the University of Maryland School of Medicine, was featured on WBAL-AM 1090 in a segment on rosacea, a condition afflicting over 14 million Americans. Dr. Vinocur addressed current therapies while reporting on a new study conducted at the Department of Dermatology, University of California, Irvine, in which rosacea patients were treated with a new cosmeceutical, Pyratine XR(TM) (0.125% furfuryl tetrahydropyranyl adenine).

Rosacea is a chronic skin disorder characterized by dilated blood vessels on the face, redness, inflammation, and lesions (papules and pustules). According to Dr. Vinocur, traditional treatments for rosacea focus on topical and oral antibiotics for their anti-inflammatory properties, but the new study showed that cytokinins, natural plant-derived growth factors known for their antioxidant and moisture retention benefits, appear to significantly reduce rosacea symptoms.

Over the 48-week study with Pyratine XR(TM) there was an overall clinical improvement in 80% of subjects with a 90% improvement in lesions, 45% improvement in redness, and a 28% improvement in spider veins. The product also appeared to improve the skin barrier function with a 41% improvement in skin dryness as early as week four while appearing to concurrently reduce fine lines, wrinkles and hyperpigmentation.

Pyratine XR(TM) is manufactured by Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging. Pyratine XR(TM) officially launched at the American Academy of Dermatology's 67th Annual Meeting in San Francisco, March 6-10, 2009.

For more information on Pyratine XR(TM), please visit www.PyratineXR.com.

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
2. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
3. Landmark Study Demonstrates Potential of Radioimmunotherapy for Treatment of Indolent B-Cell Non-Hodgkins Lymphoma
4. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
5. Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
6. Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs
7. Society of Interventional Radiology Applauds Reports Uterine Fibroid Embolization Recommendations
8. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
9. Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology
10. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
11. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... 1, 2017  The Welch Foundation, one of the ... today announced that Drs. Neal M. Alto ... recipients of the Norman Hackerman Award in ... stars, having contributed significant scientific discoveries at early stages ... the 15 years of the Hackerman Award that two ...
(Date:3/1/2017)... , March 1, 2017  The Board of Directors ... Alan Turfe as the new CEO and Chairman ... retirement of long-time Chairman and CEO William R. ... a nationwide search, and brings a wealth of experience ... industries. "In a pool of incredibly ...
(Date:2/28/2017)... , Feb. 28, 2017 Prefilled Syringes ... report: https://www.reportbuyer.com/product/4402629/ This report provides ... market on the global and regional levels. It ... from 2016 to 2024 in terms of revenue ... also includes macroeconomic indicators along with an outlook ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... 2017 , ... Today, True Vision Funding LLC (TVF), a ... a new division for the purchase of sports and music entertainment contracts, including ... Clinton Portis, former Washington Redskins running back and supporter for TVF echoed his ...
(Date:3/1/2017)... ... March 01, 2017 , ... After a long period of indulging in ... juice cleanses and workouts top the detox categories, there is a rare yet successful ... Kerry Gaynor Method’s Vital Lung Detox is an herbal-based formula designed to help cleanse ...
(Date:3/1/2017)... ... March 01, 2017 , ... Look for a new collection of edible ... Drift Roses. Star Roses and Plants is launching their new Bushel and Berry ... and Berry Collection makes growing fresh fruit simple with a variety of easy-to-grow, low-maintenance ...
(Date:3/1/2017)... ... March 01, 2017 , ... Breast Surgeon, Dr. Dennis Holmes of ... stage breast cancer and where it fits in the treatment paradigm at Susan G. ... .” The event brings together leading cancer and wellness experts to share the latest ...
(Date:3/1/2017)... ... March 01, 2017 , ... Granite Peaks ... cancer screening rates by supporting the 80% by 2018 initiative, led by the ... the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC). , ...
Breaking Medicine News(10 mins):